In 2013, substantial progress was made in uncovering the genetic basis of a variety of kidney and urological disorders, including congenital and developmental diseases. The new findings will lead to an increased understanding of the pathophysiology of these diseases, improved risk prediction and the development of novel therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sanna-Cherchi, S. et al. Mutations in DSTYK and dominant urinary tract malformations. N. Engl. J. Med. 369, 621–629 (2013).
Hart, T. C. et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882–892 (2002).
Kirby, A. et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299–303 (2013).
U. S. Renal Data System, USRDS 2012 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States Vol. 1, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, 2012).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Tzur, S. et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345–350 (2010).
Skorecki, K. L. & Wasser, W. G. Hypertension-misattributed kidney disease in African Americans. Kidney Int. 83, 6–9 (2013).
Lipkowitz, M. S. et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int. 83, 114–120 (2013).
Pezzolesi, M. G. et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58, 1403–1410 (2009).
Martini, S. et al. From SNP to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy. Diabetes 62, 2605–2612 (2013).
Acknowledgements
B. I. Freedman's work is supported in part by NIH grants RO1 DK070941 and RO1 DK084149.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Divers, J., Freedman, B. Susceptibility genes for renal and urological disorders. Nat Rev Nephrol 10, 69–70 (2014). https://doi.org/10.1038/nrneph.2013.259
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.259
